Literature DB >> 31310112

Intercepted Retro-Nazarov Reaction: Syntheses of Amidino-Rocaglate Derivatives and Their Biological Evaluation as eIF4A Inhibitors.

Wenhan Zhang1, Jennifer Chu, Andrew M Cyr1, Han Yueh1, Lauren E Brown1, Tony T Wang2, Jerry Pelletier, John A Porco1.   

Abstract

Rocaglates are a family of natural products isolated from the genus Aglaia which possess a highly substituted cyclopenta[b]benzofuran skeleton and inhibit cap-dependent protein synthesis. Rocaglates are attractive compounds due to their potential for inhibiting tumor cell maintenance in vivo by specifically targeting eukaryotic initiation factor 4A (eIF4A) and interfering with recruitment of ribosomes to mRNA. In this paper, we describe an intercepted retro-Nazarov reaction utilizing intramolecular tosyl migration to generate a reactive oxyallyl cation on the rocaglate skeleton. Trapping of the oxyallyl cation with a diverse range of nucleophiles has been used to generate over 50 novel amidino-rocaglate (ADR) and amino-rocaglate derivatives. Subsequently, these derivatives were evaluated for their ability to inhibit cap-dependent protein synthesis where they were found to outperform previous lead compounds including the rocaglate hydroxamate CR-1-31-B.

Entities:  

Year:  2019        PMID: 31310112      PMCID: PMC6693944          DOI: 10.1021/jacs.9b06446

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  53 in total

1.  Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen.

Authors:  Olivia Novac; Anne-Sophie Guenier; Jerry Pelletier
Journal:  Nucleic Acids Res       Date:  2004-02-09       Impact factor: 16.971

2.  Total synthesis of (-)-episilvestrol and (-)-silvestrol.

Authors:  Mariana El Sous; Mui Ling Khoo; Georgina Holloway; David Owen; Peter J Scammells; Mark A Rizzacasa
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

3.  An interrupted [4+3] cycloaddition reaction: a hydride shift (ene reaction) intervenes.

Authors:  Michael Harmata; Chaofeng Huang; Parham Rooshenas; Peter R Schreiner
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

4.  Enantioselective photocycloaddition mediated by chiral Brønsted acids: asymmetric synthesis of the rocaglamides.

Authors:  Baudouin Gerard; Sheharbano Sangji; Daniel J O'Leary; John A Porco
Journal:  J Am Chem Soc       Date:  2006-06-21       Impact factor: 15.419

5.  A biomimetic approach to the rocaglamides employing photogeneration of oxidopyryliums derived from 3-hydroxyflavones.

Authors:  Baudouin Gerard; Guilford Jones Ii; John A Porco
Journal:  J Am Chem Soc       Date:  2004-10-27       Impact factor: 15.419

6.  Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris.

Authors:  Bang Yeon Hwang; Bao-Ning Su; Heebyung Chai; Qiuwen Mi; Leonardus B S Kardono; Johar J Afriastini; Soedarsono Riswan; Bernard D Santarsiero; Andrew D Mesecar; Robert Wild; Craig R Fairchild; Gregory D Vite; William C Rose; Norman R Farnsworth; Geoffrey A Cordell; John M Pezzuto; Steven M Swanson; A Douglas Kinghorn
Journal:  J Org Chem       Date:  2004-05-14       Impact factor: 4.354

7.  Lewis acid-catalyzed [4 + 3] cycloaddition of 2-(trimethyl silyloxy)acrolein with furan. Insight on the nature of the mechanism from a DFT analysis.

Authors:  José A Sáez; Manuel Arnó; Luis R Domingo
Journal:  Org Lett       Date:  2003-10-30       Impact factor: 6.005

8.  Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model.

Authors:  Marie-Eve Bordeleau; Francis Robert; Baudouin Gerard; Lisa Lindqvist; Samuel M H Chen; Hans-Guido Wendel; Brigitte Brem; Harald Greger; Scott W Lowe; John A Porco; Jerry Pelletier
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

9.  Stereoselective synthesis of (+/-)-rocaglaol analogues.

Authors:  Kai Thede; Nicole Diedrichs; Jacques P Ragot
Journal:  Org Lett       Date:  2004-11-25       Impact factor: 6.005

10.  Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol.

Authors:  Regina Cencic; Marilyn Carrier; Gabriela Galicia-Vázquez; Marie-Eve Bordeleau; Rami Sukarieh; Annie Bourdeau; Brigitte Brem; Jose G Teodoro; Harald Greger; Michel L Tremblay; John A Porco; Jerry Pelletier
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

View more
  4 in total

1.  Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors.

Authors:  Jennifer Chu; Wenhan Zhang; Regina Cencic; William G Devine; Dmitri Beglov; Thomas Henkel; Lauren E Brown; Sandor Vajda; John A Porco; Jerry Pelletier
Journal:  Cell Chem Biol       Date:  2019-09-10       Impact factor: 8.116

2.  Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4F.

Authors:  Jennifer Chu; Wenhan Zhang; Regina Cencic; Patrick B F O'Connor; Francis Robert; William G Devine; Asher Selznick; Thomas Henkel; William C Merrick; Lauren E Brown; Pavel V Baranov; John A Porco; Jerry Pelletier
Journal:  Cell Rep       Date:  2020-02-25       Impact factor: 9.423

3.  Rapid and efficient synthesis of formamidines in a catalyst-free and solvent-free system.

Authors:  Zitong Zhou; Yu Zhao; Donghua Zhou; Li Li; Hui Luo; Liao Cui; Weiguang Yang
Journal:  RSC Adv       Date:  2021-10-18       Impact factor: 4.036

Review 4.  Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates-A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics.

Authors:  Gaspar Taroncher-Oldenburg; Christin Müller; Wiebke Obermann; John Ziebuhr; Roland K Hartmann; Arnold Grünweller
Journal:  Microorganisms       Date:  2021-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.